PLATO Trademark

Trademark Overview

On Friday, January 25, 2019, a trademark application was filed for PLATO with the United States Patent and Trademark Office. The USPTO has given the PLATO trademark a serial number of 88276835. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 9, 2022. This trademark is owned by AVROBIO, Inc.. The PLATO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for treatment of rare and other diseases, namely, autoimmune diseases, diseases of the central nervous system, and oncological diseases
plato

General Information

Serial Number88276835
Word MarkPLATO
Filing DateFriday, January 25, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 9, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 13, 2019

Trademark Statements

Goods and ServicesPharmaceuticals for treatment of rare and other diseases, namely, autoimmune diseases, diseases of the central nervous system, and oncological diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 21, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAVROBIO, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameAVROBIO, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, May 9, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 9, 2022ABANDONMENT - NO USE STATEMENT FILED
Saturday, October 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 30, 2021SOU EXTENSION 4 GRANTED
Thursday, September 30, 2021SOU EXTENSION 4 FILED
Thursday, September 30, 2021SOU TEAS EXTENSION RECEIVED
Thursday, April 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 6, 2021SOU EXTENSION 3 GRANTED
Tuesday, April 6, 2021SOU EXTENSION 3 FILED
Tuesday, April 6, 2021SOU TEAS EXTENSION RECEIVED
Thursday, October 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 6, 2020SOU EXTENSION 2 GRANTED
Tuesday, October 6, 2020SOU EXTENSION 2 FILED
Tuesday, October 6, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, April 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 22, 2020CORRECTED NOA E-MAILED
Tuesday, April 21, 2020SOU EXTENSION 1 GRANTED
Tuesday, March 31, 2020SOU EXTENSION 1 FILED
Tuesday, April 21, 2020DIVISIONAL PROCESSING COMPLETE
Tuesday, March 31, 2020DIVISIONAL REQUEST RECEIVED
Tuesday, April 21, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 31, 2020TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, March 31, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, October 8, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 13, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 13, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 24, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 11, 2019ASSIGNED TO LIE
Thursday, June 27, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 21, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 20, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 20, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 12, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 12, 2019NON-FINAL ACTION E-MAILED
Friday, April 12, 2019NON-FINAL ACTION WRITTEN
Monday, April 8, 2019ASSIGNED TO EXAMINER
Sunday, February 17, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

plato diseases central nervous system oncological autoimmune namely treatment rare other